List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 444 studies with search of: Ribavirin OR Virazole, Rebetol, Copegus[TREATMENT] AND HIV [CONDITION]
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Low Dose Peginterferon-α 2a for Chronic Hepatitis C, Genotypes 2 or 3, in HIV-coinfected Patients
Conditions: Hepatitis C, Chronic;   HIV Infections
Interventions: Drug: Pegylated interferon alfa-2a and Ribavirin;   Drug: Pegylated interferon alfa 2a and Ribavirin
2 Recruiting Retreatment With High Doses of pegIFN Alfa-2a and Ribavirin of Previous Nonresponders HIV-coinfected Patients With Cirrhosis Due to HCV 1-4
Conditions: Liver Cirrhosis;   Hepatitis C Virus;   HIV Infection
Intervention: Drug: Pegylated interferon alfa-2a and Ribavirin
3 Recruiting A Phase 2b, Safety and Efficacy Study of Boceprevir in Patients Coinfected With HIV and Hepatitis C (P05411 AM3)
Conditions: HIV Infections;   Hepatitis C;   HCV Infection
Interventions: Drug: PEG2b plus ribavirin followed by placebo;   Drug: PEG2b plus ribavirin followed by boceprevir/PEG2b/ribavirin
4 Completed Viral Kinetics of Treatment With Peginterferon Alpha-2a, Ribavirin and Epoetin β in Patients Coinfected HCV/HIV
Condition: HIV Infections
Interventions: Drug: Peginterferon alfa-2a, Ribavirin, epoetin-β;   Drug: Peginterferon alfa-2a + Ribavirin for 12 weeks
5 Completed Efficacy and Safety of Addition of IL-2 to Pegylated Interferon Alpha 2a and Ribavirin in HIV/HCV Coinfected Patients
Conditions: HIV Infections;   Chronic Hepatitis C
Interventions: Drug: Interleukin 2;   Drug: pegylated interferon alpha 2a;   Drug: ribavirin
6 Completed Zidovudine Levels in HIV Infected Patients Being Treated for HCV
Conditions: HIV Infections;   Hepatitis C
Interventions: Drug: Ribavirin plus interferon alfa-2b;   Drug: Ribavirin;   Drug: Peginterferon alfa-2b
7 Active, not recruiting Peginterferon Alfa-2a, Ribavirin and Epoetin β in Coinfected Patients HCV/HIV Not Responding to Previous Treatment Regimens
Conditions: Hepatitis C;   HIV Infections
Interventions: Drug: Peginterferón alfa-2a (40 KD) (Pegasys®) 180 ug/week;   Drug: Ribavirin (Copegus®) 1600 mg/day;   Drug: Epoetin β (450 UI/kg/week)
8 Completed Treatment of Chronic Hepatitis C With PEG Interferon alfa2a and Ribavirin in HIV-Infected Patients
Conditions: HIV Infections;   Hepatitis C, Chronic;   Treatment Failure
Interventions: Drug: Peginterferon alfa2a;   Drug: Ribavirin
9 Completed The Raltegravir and Ribavirin Pharmacokinetics (PK) Study
Condition: HIV Infections
Interventions: Drug: Ribavirin;   Drug: Raltegravir
10 Completed PEG-Interferon a-2b + Ribavirin for Treatment of Chronic HRN 005 Hepatitis C Infection in HIV-Infected Persons Not Previously Treated With Interferon
Conditions: Chronic Hepatitis C Infection in HIV-Infected Persons;   HIV Infections
Intervention: Drug: PEG-Interferon a-2b + Ribavirin
11 Terminated Tolerability of Peginterferon Plus Ribavirin for Chronic Hepatitis C and HIV for Patients Receiving Antiretroviral Medication vs Not Receiving Antiretroviral Medication
Conditions: Chronic Hepatitis C;   HIV Infections
Intervention: Drug: peg interferon plus ribavirin
12 Completed Phase I Pharmacokinetic and Tolerance Study of Ribavirin in Human Immunodeficiency Virus (HIV) - Infected Patients
Condition: HIV Infections
Intervention: Drug: Ribavirin
13 Completed A Phase I Study of Combination Therapy With Didanosine (ddI) and Ribavirin in HIV-Infected Children.
Condition: HIV Infections
Interventions: Drug: Ribavirin;   Drug: Didanosine
14 Completed Efficacy and Safety of PegIntron Plus Ribavirin for Treatment of Chronic Hepatitis C in HIV-Infected Subjects (Study P04469)(COMPLETED)
Conditions: Hepatitis C, Chronic;   Hepacivirus;   HIV Infections
Interventions: Biological: Peginterferon alfa-2b (SCH 054031);   Drug: Ribavirin (SCH 018908)
15 Recruiting An Open Label Non-Randomized Dose Escalating Trial to Assess Safety and Tolerability of Alb-Interferon Alfa 2b Every Two Weeks With Ribavirin Among HIV/HCV Coinfected Individuals
Conditions: HIV Infections;   HCV
Interventions: Drug: Albinterferon;   Drug: Ribavirin;   Drug: Albuferon
16 Completed A Phase I Open-Label Study of the Safety, Tolerance, and Pharmacokinetic Interactions of Combination Didanosine and Ribavirin in HIV-Positive Individuals
Condition: HIV Infections
Interventions: Drug: Ribavirin;   Drug: Didanosine
17 Recruiting Post-marketing Surveillance of HIV-infected Patients With Chronic Hepatitis C Treated With PegIntron Pen and Rebetol (Study P04584)
Conditions: Chronic Hepatitis C;   Hepatitis C;   HIV Infections
Interventions: Biological: PegIntron (peginterferon alfa-2b; SCH 54031) pen;   Drug: Rebetol (ribavirin; SCH 18908)
18 Active, not recruiting HRN 004- Peginterferon a-2a Plus Ribavirin for Chronic Hepatitis C Infection in HIV Infected Persons Who Have Failed to Achieve a Sustained Virologic Response Following Previous Interferon Therapy
Conditions: Chronic Hepatitis C Infection in HIV Infected Persons;   HIV Infections
Intervention: Drug: Peginterferon a-2a plus Ribavirin
19 Completed Interactions of Hepatitis C Viral (HCV) Dynamics and Immune Activation in HIV Coinfected Patients During HCV Treatment
Conditions: Human Immunodeficiency Virus;   Chronic Hepatitis C
Interventions: Drug: pegylated interferon-alpha (Pegasys);   Drug: ribavirin (COPEGUS)
20 Completed A Comparison of the Effectiveness, Safety, and Tolerability of Two Different Hepatitis C Treatments in Patients Infected With Both HIV and Hepatitis C Virus (HCV)
Conditions: HIV Infections;   Hepatitis C
Interventions: Drug: Ribavirin;   Drug: Interferon alfa-2a;   Drug: Peginterferon alfa-2a

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services